SAN DIEGO, Aug. 5, 2014
/PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading
company focused on improving patient and economic outcomes on a
global basis by developing and delivering innovative minimally
invasive coronary and peripheral visualization, physiology
diagnostics and therapies, said today that it will be participating
in the Canaccord Genuity Growth Conference on Wednesday, August 13.
The presentation by Scott
Huennekens, president and chief executive officer, will
begin at 1:30 p.m., Eastern Daylight
Time (10:30 a.m., Pacific Daylight
Time). The presentation will be available through the
company's website at http://www.wsw.com/webcast/canaccord14/ and
via the company's website at www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the
global leader in intravascular imaging for coronary and peripheral
applications, and physiology. The company also offers a suite of
peripheral therapeutic devices. The company's broad range of
technologies makes imaging and therapy simpler, more informative
and less invasive and offers physicians and their patients around
the world with industry-leading tools that aid diagnosis and guide
and provide therapy. Founded in cardiovascular care and expanding
into other specialties, Volcano is focused on improving patient and
economic outcomes. For more information, visit the company's
website at www.volcanocorp.com.
SOURCE Volcano Corporation